One of the big winners in the pharmaceuticals space this week was Horizon Pharma (NASDAQ: HZNP ) , up 17% in a single day on news that it was moving to Ireland to avoid higher U.S. tax rates. The company accomplished the move by buying Ireland's own Vidara Therapeutics for $660 million, and renaming the new combined company Horizon Pharma PLC. The move is expected to directly affect the bottom line, but the top line wasn't forgotten. Horizon revised guidance for its annual sales upward, boosted by sales of Vidara's drug actimmune.
In this segment from Friday's Market Checkup, Motley Fool health-care analysts David Williamson and Michael Douglass take a look at the move from Horizon, and why they expect this emerging trend in the pharma space to continue.
But how can you fight back against taxes on an individual level?
Tax increases that took effect at the beginning of 2013 affected nearly every American taxpayer. But with the right planning, you can take steps to take control of your taxes and potentially even lower your tax bill. In our brand-new special report "How You Can Fight Back Against Higher Taxes," The Motley Fool's tax experts run through what to watch out for in doing your tax planning this year. With its concrete advice on how to cut taxes for decades to come, you won't want to miss out. Click here to get your copy today -- it's absolutely free.